This groundbreaking initiative is a valuable opportunity for start-ups and innovative enterprises struggling to secure fermentation capacity during a critical industry shortage.
FaaS promises to provide companies with unparalleled access to essential tools and expertise, enabling them to efficiently scale-up their fermentation operations from volumes as low as 300 L to an astounding 90,000 L.
FaaS empowers companies to overcome challenges related to product quality, yield and cost management as they make the leap to commercial production.
Ranjan Patnaik, Chief Technology Officer at MycoTechnology, elaborated: “Fermentation is a critical process that underpins the production of a wide array of bioproducts. However, scaling-up can be fraught with difficulties; fierce competition for fermentation capacity is resulting in bottlenecks, delays and escalating costs.”
“These factors are creating major barriers to entry into the sector. But, by opening up our facility to others, we aim to foster breakthroughs and accelerate the pace of innovation.”
The FaaS platform accommodates a diverse range of bioproducts, including proteins, enzymes and probiotics. It operates under rigorous regulatory standards, adhering to 21 CFR Part 117 guidelines and boasting a GFSI audit certification from BRCGS, ensuring a robust and reliable facility for fermentation services.
In an era when the US biomanufacturing sector is actively working to bridge the fermentation capacity gap, supported by initiatives such as the BioMADE programme, MycoTechnology’s FaaS emerges as a pivotal player.
This initiative not only aligns with the growing efforts to enhance the US bioindustrial landscape, but also paves the way for other companies facing capacity constraints to envision a future filled with potential and innovation.
MycoTechnology will be exhibiting at SupplySide West (Booth 3519), with experts on hand to answer questions about the FaaS platform and discuss all aspects of the fermentation process.
The spotlight will also be cast on MycoTechnology’s own fermented protein solutions, showcasing how the company is revolutionising plant-based dairy alternatives through advanced nutrition, taste and texture.
